Background {#Sec1}
==========

*Euphorbia lathyris* L. is an effective but toxic traditional Chinese medicine (TCM) derived from the family of euphorbiaceae. It can expel water retention with drastic purgative effects, namely, breaking up the static blood and eliminating masses and is often used for the treatment of hydropsy, ascites, anuresis and constipation, amenorrhea, scabies \[[@CR1], [@CR2]\]. It shows several side effects such as irritation and inflammation intense on the skin, mouth and gastrointestinal tract irritation, carcinogenic, and so on. The gastrointestinal mucosa irritation mainly manifested as serious diarrhea. Traditionally, Semen Euphorbiae Pulveratum (SEP), which is another type of *Euphorbia lathyris* L., is commonly used in TCM practice and is obtained by removing the oil from the seed which is called paozhi. After processing, the toxicity and the capacity of diarrhea was decreased obviously \[[@CR3]\]. Interestingly, considerable research efforts have been devoted to the studies on the effect of SEP and SE on diarrhea. Whereas, the intestine protein changes related to intestinal toxicity and the main mechanisms of reducing toxicity by processing of SE remain poorly understood.

With the improvement of two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and mass spectrometry \[[@CR4]\], considerable research efforts have been devoted to the application of proteomics to find possible involved signals in toxic injure induced by some toxins or to determine the modes of action and mechanisms involved in drug- or chemical-induced toxicity \[[@CR5], [@CR6]\]. The isobaric tags for relative and absolute quantitation (iTRAQ) technique is one of the most widely used, innovative and common quantitative proteomics approaches that measure the qualitative and quantitative changes in protein content of a cell or tissue in response to treatment or disease and determine protein-protein and protein-ligand interactions \[[@CR7]\]. It can simultaneously analyze 4--8 different specimens, thus increasing throughput while reducing experimental error \[[@CR8], [@CR9]\]. iTRAQ labeling coupled with LC-MS/MS is sensitive, automated, and multidimensional and can detect large molecules (\> 20 kDa) \[[@CR10]\]. ITRAQ is suitable for exploratory studies of the processing mechanisms.

In our study, we applied iTRAQ approach to processing for *Euphorbia lathyris*-induced intestinal toxicity and to identify candidate biomarkers for main mechanisms underlying processing of SE. Bioinformatics analysis including GO analysis, pathway analysis, and network analysis were done to find possible differential pathways. Additionally, the investigation suggested that Euphorbiae factor 1(EFL~1~), isolated from *Euphorbia lathyris*, is the main and active diterpenoids which might mediate diarrhea \[[@CR11]\]. We also demonstrated EFL~1~ group to further compare the DEPs induced by SE and SEP. Finally, western blot analysis was applied further to identify candidate biomarkers, and to confirm and validate significance of the proteomic findings. These results provided a first insight into scientific connotation of hypothesis that the attenuated of SE after processing expressed lower toxicity from cellular levels in mice model and described an efficient method for mechanisms of toxic TCM processing.

Methods {#Sec2}
=======

Samples {#Sec3}
-------

### Experimental animals {#Sec4}

KM mice (SPF grade, 18--22 g) were purchased from Sibeifu Co., Ltd. (Beijing, China). All experiments were approved by the Animal Care Committee. Mice were kept at room temperature (23 ± 1 °C) and 55 ± 5% humidity. All experiments were conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animal, as adopted by the Committee on Animal Research at Beijing University of Chinese Medicine.

### Extracts preparations of semen euphorbiae and semen euphorbiae Pulveratum {#Sec5}

Pieces of Euphorbiae Semen (batch number, 1203070692; origin, Jiangxi province, China) were purchased from Anhui Bozhou HuQiao Chinese Herbal Pieces plant. Petroleum ether extract of Semen Euphorbiae, petroleum ether extract of Semen Euphorbiae Pulveratum was provided by Shandong University of Traditional Chinese Medicine. The extraction and isolation methods of Semen Euphorbiae had been published in these articles \[[@CR12], [@CR13]\]. Euphorbiae factor 1 was isolated from the petroleum ether extracts of semen Euphorbia by our team \[[@CR13], [@CR14]\].

Proteomics extraction procedures {#Sec6}
--------------------------------

### Protein preparation {#Sec7}

After 12 h of fasting, KM mice were randomly divided into 4 groups (*n* = 10 for each group): the group 1 was served as a control, and received only blank 1% sodium carboxymethyl cellulose solution; meanwhile group 2 was the extracts of SE and group 3 was the extraction of SEP, in which the mice were orally administered at the dose of 1.5 ml/20 g and 1.0 ml/20 g, respectively, with the same amount of crude drug. In order to validate the results induced by SE and SEP, group 4 was administered 20 mg/20 g Euphorbiae factor 1(EFL~1~) to further verify the protein networks. Mice then received standard diet and water ad libitum. 6 h later, mice were sacrificed, from which the colon were obtained and frozen in liquid nitrogen immediately until they were used for analysis.

### Protein isolation {#Sec8}

The colon tissue samples were ground into powder in liquid nitrogen, extracted with Lysis buffer (7 M urea (Bio-Rad, 161--0731), 2 M Thiourea (Sigma-Aldrich, T7875), 4% CHAPS (Bio-Rad, 161--0460)) containing complete protease inhibitor Cocktai (Roche, 04693116001). The cell was lysed by sonication at 200 W for 60s and then extracted 30 min at room temperature, centrifuged at 4 °C, 15000 g for 20 min. Before the protein processing, each 5 individual protein samples were mixed equally into 1 specimen. As a result of the strategy, each group contained 2 sample pools, and these sample pools were enrolled to be conducted in subsequent experiments*.*

### Bradford analysis {#Sec9}

Total protein concentration of the samples was determined using a Bradford Assay \[[@CR15]\]. Standards of BSA were prepared and all samples and standards were analyzed in duplicate. Protein concentrations and standards of BSA were determined at 595 nm on an Multiskan MK3 UV--vis spectrophotometer (Thermo, U.S.) with 10 μL sample reacted with 300 μL Thermo Scientific Pierce Coomassie Plus Bradford Assay (Part No. 23238) 20 min.

### Protein reduction, alkylation, and digestion {#Sec10}

Filter-aided sample preparation (FASP) method was used to digest protein based on Jacek R Wis'niewski et al. \[[@CR16]\]. The 200 μg calculated protein samples were added to centrifuge tube and 25 mM DTT was added and the samples were incubated at 60 °C for 1 h. Samples were incubated for 10 min in the dark after adding 50 mM IAA at room temperature and then centrifuged at 12,000 rpm for 20 min using Ultrafiltration centrifugal tube(NWCO:10 K). 100 μL Dissolution Buffer(iTRAQ ® Kit Dissolution Buffer, AB Sciex, USA, PN:4381664) was added to the filter and centrifuged at 12,000 rpm for 20 min. This step was repeated three times.50 μL trypsin, totally 4 μg, was added and samples were incubated at 37 °C overnight. After trypsin digestion, samples were centrifuged at 12,000 rpm for 20 min, the digested peptides were collected at the bottom of the tube and mixed with 50 μL Dissolution Buffer. Finally 100 μL samples were obtained.

### iTRAQ labeling {#Sec11}

Each iTRAQ reagent tube (tags-113-121) had 150 μl isopropanol added and vortexed thoroughly, then centrifuged. 50 μl samples (equal to 100 μg digested peptides) were transferred to new tubs and processed according to the manufacturer's protocol for 8-plex iTRAQ reagent (AB Sciex, PN:4390812) by incubation at RT for 2 h with gentle shaking. The labeled peptide mixtures were then pooled and dried by vacuum centrifugation. Samples were labeled respectively with different isobaric tags as follow: EFL~1~ samples labeled 113 and 114, control samples labeled 115 and 116, and extraction of SE samples labeled 117 and 118, extraction of SEP samples labeled 119 and 121. The peptides were labeled with the isobaric tags, incubated at room temperature for 2 h. The labeled peptide mixtures were then pooled and dried by vacuum centrifugation.

### iTRAQ-labeled peptide fractionation and proteomic analysis by LC-MS/MS {#Sec12}

The iTRAQ-labeled peptide mixtures were re-suspended in buffer A (2% ACN, pH 10) and centrifuged at 14,000 g for 20 min. High pH reversed-phase chromatography was performed to separate the trypsin digestion peptide. The supernatant was loaded onto a 4.6 × 250 mm Durashell-C~18~ containing 5-μm particles. The peptides were eluted at a flow rate of 0.7 mL/min with a 51-min gradient:0-10 min,5.0% B (Mobile phaseA:2%ACN,98%ddH~2~O,pH 10;Mobile phaseB:98%ACN,2%ddH~2~O,pH 10);10--13.4 min,5%-8.%B;13.4--31.7 min,8.5%--20.5%B;31.7-41 min,20.5%--31.0%B; 41-46 min,31%--90%B;46-47 min,90.0--95.0%B;47-48 min, 95%--5%B;48-51 min,5%B. The eluted peptides were obtained 40 fractions and finally pooled into 10 fractions through Peak shape.

Then the fraction was re-suspended in 20 μL buffer A (2% ACN, 0.1% FA)and centrifuged at 12,000 rpm for 10 min and 10 μL supernatant was loaded onto a 12 cm × 75 μm EASY-Spray column (C~18~,3 μm). The samples were loaded at 300 nL/min with mobile phase A: 100% dd H~2~O/0.1% Formic acid; mobile phase B: 100% ACN/0.1%FA. The gradient as follows:0-13 min,5--8%B;13-90 min,8030%B;90-100 min,30--50%B;100-105 min,50--95%B;105-115 min,95%B;115-116 min,95--5%B;116-126 min,5%B.

The peptides were subjected to Nano-electrospray ionization followed by mass spectrometry (MS/MS) using a Q-Exactive mass spectrometer (Thermo Scientific) coupled with an online micro flow HPLC system. Key parameter settings for the Thermo Q-Exactive mass spectrometer were as follows:

spray voltage floating (ISVF) 2.3KV, Capillary Temperature:320 °C, Ion source: EASY-Spray source, declustering potential (DP) 100 V.

Full MS:Resolution:70000FWHM;Full Scan AGC target:3e6;Full Scan Max.IT:20 ms;Scan range:300-1800 m/z;

dd-MS2:Resolution:17500 FWHM;AGC target:1e5;Maximum IT:120 ms;Intensity threshold:8.30E + 03;Fragmentation Methods:HCD;NCE:32%;Top N:20.

Bioinformatics analysis {#Sec13}
-----------------------

Annotations of identified proteins were done with GO for biological processes, molecular functions and cellular component. The analysis were carried out using the Database for Annotation Visualization and Integrated Discovery. Tagged samples were normalized by comparing median protein ratios for the reference channel. Protein quantitative ratios were calculated from the median of all peptide ratios. The proteins with a relative expression of \> 1.32 or \< 0.68, and with a *P*-value \< 0.05 selected as statistically significance to ensure up- and downregulation authenticity. The selection parameter was based on the overrepresented GO terms with gene enrichment analysis of *p* \< 0.05. The protein lists were further analyzed by UniProt database (<http://www.uniprot.org/uniprot/?query=taxonomy:10090>) which gave all canonical pathways, interactions, and network construction with significant enrichment of the input proteins based on data from the UniProt Database, Biocarta, etc. \[[@CR17]\]

Western blot analysis {#Sec14}
---------------------

Western blot analysis were performed to confirm the presence of differentially expressed proteins. Colons from mouse were washed with ice-cold saline and triturated under Liquid Nitrogen. 200 mg powder were lysed in 1.5 ml RIPA buffer and incubated on ice for 60 min, sonicated for 60s, followed by centrifugation at 12,000×g for 15 min at 4 °C. The total protein concentration was measured using the BCA protein assay kit (Applygen Technologies Inc. Beijing, China). The supernatant lysates were diluted in 5× SDS sample buffer and boiled for 5--10 min.

Proteins from individual samples were separated on SDS-PAGE gels and transferred electrophoretically onto PVDF membranes (Millipore, Billerica, MA, USA). The membranes were blocked for 2 h at room temperature with 3% non-fat dried milk in Tris-buffered saline (TBST, 20 mM Tris-HCl, 137 mM NaCl, and 0.1% Tween 20, pH 7.6). Then, the membranes were incubated overnight at 4 °C in a primary antibody against Anti-STAT1 antibody(Abcam, USA), Rabbit Anti-Angiopoietin 4(Beijing Biosynthesis Biotechnology Co., Ltd.,China), Rabbit and Mouse Anti-β-actin(ZS-Bio. Co., Ltd. Beijing, China). The membranes were then washed with TTBS three times and incubated with horseradish peroxidase-conjugated secondary antibodies (ZS-Bio. Co., Ltd. Beijing, China), Peroxidase-Conjugated Goat anti-Mouse IgG (H + L) (ZB-2305) and Peroxidase-Conjugated Goat anti-Rabbit IgG (H + L) (ZB-2301).Proteins were detected using an enhanced chemiluminescence (ECL) method (Super ECL plus Detection Reagent, Applygen Technologies Inc.P1010). Protein bands were imaged using a ChemiScope 3300 Mini bio-imaging system (Clinx Science Instruments Co., Ltd. (CSI), Shanghai, China). Bands were normalized with β- actin as an internal control. Protein expressions were quantified by chemi analysis and Ang4 and STAT1 were normalized to the beta-actin of each sample. These experiments were each conducted five times.

Results and discussion {#Sec15}
======================

Protein profiling {#Sec16}
-----------------

MS raw data files were converted into MGF files using Proteome Discoverer 1.4 (PD 1.4, Thermo), and the MGF data files were searched by using the Mascot search engine (Matrix Science, London, UK; version 2.3.02) to identify proteins. Each confident protein identification involves at least one unique peptide. For protein quantification, it was required that a protein contained at least two unique spectra. The quantitative protein ratios were weighted and normalized by the median ratio in Mascot. As shown in Fig. [1](#Fig1){ref-type="fig"}, a total of 393,357 MS/MS spectra which are the secondary mass spectrums were identified by iTRAQ-coupled 2D LC-MS/MS analysis in mice intestine tissues. Among them, 123,136 peptide spectrum-match (PSM) were found. In addition, the LC-MS/MS analysis employed here resulted in identification of 50,007 total peptides with 6727 identified protein groups.Fig. 1Basic information statistics of proteome by iTRAQ. MS/MS spectra are the secondary mass spectrums, and PSMs are the secondary mass spectrums after quality control. Protein is identified by Proteome Discoverer 1.4 software

Identification of differentially expressed proteins using iTRAQ labeling and LC-MS/MS {#Sec17}
-------------------------------------------------------------------------------------

Through analysis with software, data were processed using the Proteome Discoverer Software 4.0 utilizing the Mascot (Matrix Science,London, U.K.; version 2.3.0) Algorithm. In this algorithm, Parameters set for the searching were iTRAQ eight plex peptide-labeled, trypsin digestion with only two maximum miss cleavage, carboxymate for cysteine residue and oxidation for methionine. The tolerances were specified as ±15 ppm for peptides and ± 20 mmu for MS/MS fragments. The mice protein database was downloaded from UniProt. The false discovery rate (FDR) was controlled at the 1% level. Distributional normality and homogeneity of variance were tested for numerical data. Values were given as mean ± SD. To reduce probability of false peptide identification, only peptides with a fold change cut-off ratio of \> 1.32 or \< 0.68 and ones with *p*-values smaller than 0.05 in the analysis (where *P*-value \< 0.05 indicates \> 95% confidence of a change in protein concentration irrespective of the magnitude of the change) was selected to designate differentially expressed proteins. The similar experimental design was described in previous study \[[@CR18]--[@CR20]\]. Among them, proteins that displayed significantly altered expression levels comparing with the control group were considered as up-regulated or down-regulated differentially expressed proteins (DEPs), respectively. With this filter, we identified 103 DEPs in EFL~1~ group, including 82 up-regulated proteins and 21 down-regulated proteins. Besides, regarding to 70 DEPs from SE-treated group compared to control group, 47 proteins were up-regulated, and 23 proteins were down-regulated. Moreover, there were 96 up-regulated proteins and 26 down-regulated proteins, totaling 122 proteins in the SEP-treated groups were identified relative to control. Further analysis indicated that the three test groups shared 7 DEPs in the colon tissues of mice after intersection, of which, 5 proteins were down-regulated and 2 proteins up-regulated (Table [1](#Tab1){ref-type="table"}). Meanwhile, there were 295 differentially expressed proteins in the [colon]{.ul} tissues of mice in union of DEPs of SE and SEP, EFL~1~, of which, 70 proteins were down-regulated and 225 proteins up-regulated (Table [2](#Tab2){ref-type="table"}). These proteins were subjected to gene-ontology enrichment.Table 1Related information of differentially expressed protein (DEPs) by iTRAQ analysis after intersectionAcc no. (NCBI)Prot namesGene namesControlSESEPEFL~1~Down-regulated proteinsQ3TMQ6Angiogenin-4Ang410.57950.60820.549Q62010Oviduct-specific glycoproteinOvgp110.42520.58250.451Q80ZA0Intelectin-1b (Intelectin-2)Itln1b10.48470.67150.498Q8R1M8Mucosal pentraxinMptx110.53520.56520.559V9GXU2C2 domain-containing protein 3C2cd310.53720.6360.463Up-regulated proteinsF6R782IQ domain-containing protein EIqce13.4964.44374.691Q9D1X0Nucleolar protein 3 (Apoptosis repressor with CARD)Nol3 Arc11.36651.51671.345*Acc no* Accession number, *Prot name* Protein name, *SE* Semen Euphorbiae, *SEP* Semen Euphorbiae Pulveratum, *EFL*~*1*~ Euphorbiae Factor 1Table 2Summary table showing significantly up-regulated or down-regulated proteins identified by iTRAQ Analysis after combine togetherAcc no.(NCBI)Pro namesGene namesControlSEEFL~1~SEPUp-regulatedQ62010Oviduct-specific glycoproteinOvgp1 Chit5 Ogp10.42520.4510.5825A2BDX4Potassium voltage-gated channel subfamily G member 1Kcng110.43470.8560.6645P97816Protein S100-GS100 g Calb3 S100d10.44850.5990.653Q8BV14Ankyrin repeat domain-containing protein 55Ankrd5510.46520.636/Q80ZA0Intelectin-1b (Intelectin-2)Itln1b Itln2 Itlnb10.48470.4980.6715Q8R1M8Mucosal pentraxinMptx1 Mptx10.53520.5590.5652V9GXU2C2 domain-containing protein 3C2cd310.53720.4630.636P07146Anionic trypsin-2Prss2 Try210.54650.7760.5967D6RFD6Protein RFT1 homologRft110.56870.7714.6342Q8VCV1Alpha/beta hydrolase domain-containing protein 17CAbhd17c10.57071.2710.7095Q3TMQ6Angiogenin-4Ang410.57950.5490.6082Q08189Protein-glutamine gamma-glutamyltransferase ETgm3 Tgase310.60850.7280.528Q8CIM3D-2-hydroxyglutarate dehydrogenase, mitochondrialD2hgdh10.610.7041.0195Q9D7Z6Calcium-activated chloride channel regulator 1Clca110.6490.7090.637O88273Gremlin-2 (Protein related to DAN and cerberus)Prdc10.65420.9061.7397D6RFQ5p53 and DNA damage-regulated protein 1Pdrg110.65850.6830.6567Q8BYF6Sodium-coupled monocarboxylate transporter 1Slc5a8 Smct Smct110.66670.9720.767H3BLD0ATP synthase mitochondrial F1 complex assembly factor 1Atpaf110.66870.8410.9637Q8BXQ3Leucine-rich repeat and transmembrane domain-containing protein 1Lrtm110.67020.9820.573A0A075B5L8Protein Igkv4--79Igkv4--7910.67220.6880.8432Q3V341Protein kinase C zeta typePrkcz10.67750.6061.052O88310Intelectin-1aItln110.67820.6960.7225Q9D2X6Colon SVA-like proteinSval1 mcsp mCG_1708410.67820.9120.5127Q64339Ubiquitin-like protein ISG15Isg15 G1p2 Ucrp10.68870.9220.6737Q810Q5Normal mucosa of esophagus-specific gene 1 proteinNmes110.6930.8320.5877P21550Beta-enolaseEno3 Eno-310.69650.8760.6672P56392Cytochrome c oxidase subunit 7A1, mitochondrialCox7a110.72570.7550.655P30275Creatine kinase U-type, mitochondrialCkmt110.74920.8510.6657Q6T707Protein Scd4 (Stearoyl-CoA desaturase-4)Scd410.7681.8081.1152Q9NYQ2Hydroxyacid oxidase 2 (HAOX2)Hao2 Hao3 Haox210.7710.7210.658P09036Serine protease inhibitor Kazal-type 3Spink310.77650.9870.595P98086Complement C1q subcomponent subunit AC1qa10.7850.4060.8317F8VPP8Protein Zc3h7bZc3h7b10.78870.6770.787Q5RI75--2Ras and EF-hand domain-containing protein homologRasef10.78920.6510.6965A2AGQ3MAP kinase-activating death domain proteinMadd10.79321.3271.398E9QNL5SulfotransferaseSult1a110.7960.6590.7287P00329Alcohol dehydrogenase 1Adh1 Adh-110.79921.0360.5625Q3UZZ6Sulfotransferase 1 family member D1Sult1d1 St1d110.810.6320.7565B2RT41Protein Zfc3h1Zfc3h1 Ccdc13110.8310.9210.6362P57774Pro-neuropeptide Y \[Cleaved into: Neuropeptide YNpy10.8351.4361.1532Q3UW68Calpain-13 (Calcium-activated neutral proteinase 13)Capn13 Gm94310.8380.9870.669P13634Carbonic anhydrase 1Ca1 Car110.84250.6220.818Q9WUG6Insulin-like peptide INSL5 (Insulin-like peptide 5)Insl5 Rif Rif2 Zins310.8611.4290.6775F7BQ76MPN domain-containing protein (Fragment)Mpnd10.86170.6031.577P56393Cytochrome c oxidase subunit 7B, mitochondrialCox7b10.87551.0750.6255Q80WK2Organic solute transporter subunit betaSlc51b Ostb10.8811.3731.177A2A6K0Troponin I, fast skeletal muscleTnni210.8860.3740.965Q7TPR4Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform)Actn110.8880.8570.6745G3X940Histone acetyltransferaseKat6a Myst310.88871.6181.1427P01796Ig heavy chain V-III region A4010.89351.4811.0095G3UVW7Protein Zfp40 (Zinc finger protein 40)Zfp40 mCG_1352210.90521.531.0887Q9EPS2Peptide YYPyy10.91351.3490.974G3XA21MCG134445, isoform CRA_a (Protein Mroh1)Mroh1 Heatr7a10.9221.1141.3435Q9Z179SHC SH2 domain-binding protein 1Shcbp1 Pal10.92951.1071.4725I6L974TBC1 domain family member 17Tbc1d1710.93151.1551.3645P01631Ig kappa chain V-II region 26--10010.93871.750.821P01878Ig alpha chain C region010.9421.3320.8282P57776--2Elongation factor 1-delta (EF-1-delta)Eef1d10.94770.8980.6252D3Z6J0HemK methyltransferase family member 2, isoform CRA_bN6amt1 Hemk2 mCG_13000210.95621.5241.4077Q9WUH1Transmembrane protein 115 (Protein PL6 homolog)Tmem115 Pl610.9621.1611.4085Q8R1U2Cell growth regulator with EF hand domain protein 1Cgref1 Cgr1110.96350.9311.4472A0A087WNJ2Deleted.010.9740.6410.7125E0CYM0Protein 1700019G17Rik1700019G17Rik10.97521.3761.0687D3Z7B5Protein C330027C09RikC330027C09Rik10.9781.3361.1042D3Z652Testis-expressed sequence 35 proteinTex3510.97970.9931.3665F8VQE9ANK repeat and PH domain-containing protein 3Agap310.98551.0261.6535O88665Bromodomain-containing protein 7Brd7 Bp7510.98950.9281.5765E9Q933Transmembrane protein 11, mitochondrialTmem1110.99421.51.1595down-regulated6NXH9Keratin, type II cytoskeletal 73Krt73 Kb36114.2651.5591.4102F6R782IQ domain-containing protein EIqce13.4964.6914.4437A0A075B6A3Protein IghaIgha12.72171.2081.9125P00687Alpha-amylase 1Amy112.55754.3413.1215Q8C804Spindle and centriole-associated protein 1Spice1 Ccdc5212.37421.9281.8472O88273Formin-2Fmn212.21072.2343.8712D3Z1G3Multiple coagulation factor deficiency protein 2 homologMcfd212.20851.6941.931A2AHB7Potassium channel subfamily T member 1Kcnt112.1811.355.51G3UZX8Probable JmjC domain-containing histone demethylation protein 2CJmjd1c12.17451.1243.0692P35991Tyrosine-protein kinase BTKBtk Bpk12.10571.3021.5725P70213Friend virus susceptibility protein 1Fv111.8471.2071.5947A0A075B664Protein Iglv2Iglv211.82573.0161.2922E9Q9F6--2Cation channel sperm-associated protein subunit deltaCatsperd Tmem14611.79071.1320.6605P57791CAAX prenyl protease 2Rce1 Face2 Rce1a11.67721.1031.4677Q9QZU9Ubiquitin/ISG15-conjugating enzyme E2 L6Ube2l6 Ubce811.6483.0262.0062A2AF82Activator of 90 kDa heat shock protein ATPase homolog 2Ahsa211.60571.3631.5F8VQM0Alkaline phosphataseAkp311.60221.2822.631P11034Mast cell protease 1Mcpt111.6021.7041.5607Q6ZWN540S ribosomal protein S9Rps911.56221.0531.3207Q9DBB8Trans-1,2-dihydrobenzene-1,2-diol dehydrogenaseDhdh11.55851.2681.6725Q6NZQ2DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31Ddx3111.53051.1691.3397G5E8C3G protein-coupled receptor, family C, group 5, member AGprc5a mCG_2226211.50771.1681.4337Q91WP6Serine protease inhibitor A3NSerpina3n Spi211.5020.9951.2225A2A3U8LON peptidase N-terminal domain and RING finger protein 3Lonrf311.50171.2741.9312P07759Serine protease inhibitor A3KSpi211.48250.8041.2742Q9DCG2--2CD302 antigenCd302 Clec13a11.4691.1161.786P27005Protein S100-A8 (Calgranulin-A)S100a8 Caga Mrp811.46371.5221.154P04227H-2 class II histocompatibility antigen, A-Q alpha chainH2-Aa11.46171.3820.916Q8C6B9Active regulator of SIRT1Rps19bp1 Aros11.45551.0941.78P70412CUB and zona pellucida-like domain-containing protein 1Cuzd1 Itmap111.43651.3251.5315Q9D083--3Kinetochore protein Spc24Spc24 Spbc2411.42971.9782.0805P62984Ubiquitin-60S ribosomal protein L40Uba52 Ubcep211.42471.3361.143P12804FibroleukinFgl2 Fiblp11.42151.4071.7527J3QPY0Protein 1600014C10Rik1600014C10Rik11.41651.4851.8247B1AXR3Perilipin-2Plin211.4140.9751.3562Q9ESG9Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinasePkmyt1 Myt111.41371.3321.9545P07758Alpha-1-antitrypsin 1--1 (AAT)Serpina1a Dom1 Spi1--111.40850.9081.1527Q8C7E9Cleavage stimulation factor subunit 2 tau variantCstf2t Kiaa068911.4011.0821.014F6ZQQ326S proteasome non-ATPase regulatory subunit 13Psmd1311.39351.4172.6332Q91XL1Leucine-rich HEV glycoprotein (Protein Lrg1)Lrg1 Lrg lrhg11.39320.9491.327Q03145Ephrin type-A receptor 2Epha2 Eck Myk211.39321.1861.522Q9QXA1Cysteine and histidine-rich protein 1Cyhr1 Chrp11.39021.1911.0515Q8BHZ4Zinc finger protein 592 (Zfp-592)Znf592 Kiaa021111.38651.3381.3052P07724Serum albuminAlb Alb-1 Alb111.38420.8161.2217V9GX06Protein Gm11214Gm1121411.38351.0981.3607P29699Alpha-2-HS-glycoprotein (Countertrypin)Ahsg Fetua11.3820.7741.1715P1414860S ribosomal protein L7Rpl711.37050.9531.1725P42232Signal transducer and activator of transcription 5BStat5b11.37051.6271.311P3598060S ribosomal protein L18Rpl1811.36950.9631.176Q9D1X0Nucleolar protein 3 (Apoptosis repressor with CARD)Nol3 Arc11.36651.3451.5167G3X8Z1Calcium-activated chloride channel regulator 4AmCG_11958811.3661.0081.3725P01741Ig heavy chain V region (Anti-arsonate antibody)011.36473.7091.06A0A087WQ94Protein Tns1Tns111.35621.1170.9982A2AAC0Chymotrypsin-CCtrc11.3541.0621.3185E9Q8K5TitinTtn11.35320.7441.6037Q3U3Q1--2Serine/threonine-protein kinase ULK3Ulk311.3531.1881.574Q91YU8Suppressor of SWI4 1 homologPpan Ssf111.35221.1671.1937Q6LC96RXR alpha 2 (RXR alpha 3)Rxra RXR alpha11.3290.9841.2152Q3UPV6Voltage-gated potassium channel subunit beta-2Kcnab211.3281.5681.183P6230140S ribosomal protein S13Rps1311.32751.0931.1617P22599Alpha-1-antitrypsin 1--2 (AAT) (Alpha-1 protease inhibitor 2)Serpina1b Aat211.3260.8491.1235Q9EP52Twisted gastrulation protein homolog 1Twsg1 Tsg11.32421.1970.9917E9PV04Protein Gm8994Gm8994 Gm557611.32371.141.2215P15119Mast cell protease 2Mcpt211.3221.361.0482Q3ZAR9Nr2c2 protein (Nuclear receptor subfamily 2 group C member 2)Nr2c211.32021.3951.158Q8BSI6R3H and coiled-coil domain-containing protein 1R3hcc111.3191.2791.569Q32M21--2Gasdermin-A2Gsdma2 Gsdm211.31251.4821.233Q80TL0Protein phosphatase 1EPpm1e Camkn11.30820.6451.1805F6RUC3Ribonucleoside-diphosphate reductase subunit M2 (Fragment)Rrm211.30751.2381.4467A2ALH2Putative tRNAFtsj111.2961.31.5377Q8BGS0--2Protein MAK16 homolog (Protein RBM13)Mak16 Rbm1311.29271.1951.334Q8BHY2Nucleolar complex protein 4 homolog (NOC4 protein homolog)Noc4l11.28771.4551.5922Q99J23GH3 domain-containing proteinGhdc D11lgp1e11.2871.2311.3732O35640Annexin A8Anxa8 Anx811.2771.551.1167Q60590Alpha-1-acid glycoprotein 1Orm1 Agp1 Orm-111.2631.1161.4175P35461Lymphocyte antigen 6G (Ly-6G)Ly6g11.24950.9151.331P42225Signal transducer and activator of transcription 1Stat111.24371.5330.9722Q8VEJ4Notchless protein homolog 1Nle111.24321.2511.3997F6S522ClaspinClspn11.24151.1347.6765Q8BHN5RNA-binding protein 45Rbm45 Drb1 Drbp111.23871.2321.4235P31725Protein S100-A9S100a911.23451.3511.028F8WJ43MerlinNf211.2341.1681.441Q8C3X8Lipase maturation factor 2Lmf2 Tmem112b Tmem15311.23070.9281.5145E9Q8D0Protein Dnajc21Dnajc2111.2271.4761.1372Q9QXA1--2Cysteine and histidine-rich protein 1Cyhr1 Chrp11.22051.3741.054Q3UW98Chloride channel calcium activated 7Clca4b AI74744811.21871.4011.0597A0A075B5M8Protein Igkv12--38Igkv12--3811.2181.3371.2272Q4QRL3Coiled-coil domain-containing protein 88BCcdc88b Ccdc8811.21721.4851.392Q3TBT3--3Stimulator of interferon genes protein (mSTING)Tmem173 Eris Mita11.21671.4411.1297P08905Lysozyme C-2 (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C) (Lysozyme C type M)Lyz2 Lyz Lyzs11.21621.3531.0305Q9DCS1Transmembrane protein 176A (Gene signature 188) (Kidney-expressed gene 2 protein)Tmem176a Gs188 Keg211.21571.2481.5587P84228Histone H3.2Hist1h3b11.2140.5111.0842D3Z408High affinity cGMP-specific 3′,5′-cyclic phosphodiesterase 9APde9a11.21371.3071.3392E9Q4G7Casein kinase I isoform alphaCsnk1a111.21051.471.643P05533Lymphocyte antigen 6A-2/6E-1 (Ly-6A.2/Ly-6E.1) (Stem cell antigen 1) (SCA-1) (T-cell-activating protein) (TAP)Ly6a Ly611.20851.3781.1695P01844Ig lambda-2 chain C regionIglc211.20722.4411.087G3X8S8MCG14499 (tRNA-splicing endonuclease subunit Sen15)Tsen15 mCG_1449911.20651.1431.4907F6QQ13Selenocysteine insertion sequence-binding protein 2-like (Fragment)Secisbp2l11.20351.1491.3285P58501PAX3- and PAX7-binding protein 1 (PAX3/7BP) (GC-rich sequence DNA-binding factor 1)Paxbp1 Gcfc Gcfc111.20351.4881.2637Q9JLM9Growth factor receptor-bound protein 14 (GRB14 adapter protein)Grb1411.19750.6011.1215P59328--2WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1)Wdhd1 And111.19221.2211.4022A2A5Z6--2E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2)Smurf211.19021.0981.3955Q8CIA9Hippocampus abundant transcript-like protein 1Hiatl111.18521.0981.3277H3BKB9Protein zwilch homolog (Fragment)Zwilch11.18171.1141.3972Q5SUA5Unconventional myosin-IgMyo1g11.17471.1961.3717P03991H-2 class I histocompatibility antigen, K-W28 alpha chainH2-K1 H2-K11.16821.5540.966Q61542StAR-related lipid transfer protein 3 (Protein ES 64) (Protein MLN 64) (START domain-containing protein 3) (StARD3)Stard3 Es64 Mln6411.16721.6631.496A8C756Thyroid adenoma-associated protein homologThada Kiaa176711.1651.2991.382Q80ZI6E3 ubiquitin-protein ligase LRSAM1 (EC 6.3.2.-) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (Tsg101-associated ligase)Lrsam111.16271.0941.59F6RR81Protein cordon-bleu (Fragment)Cobl11.15851.3551.1932Q8R2S8CD177 antigen (CD antigen CD177)Cd17711.1581.4261.0102A2ALA0Surfeit locus protein 6Surf611.15671.2181.3962Q5SUW0Growth factor receptor-bound protein 10 (Fragment)Grb1011.15521.0191.3747Q9CQS2H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10)Nop10 Nola311.14551.371.1737D3YUW8Pogo transposable element with ZNF domainPogz11.13651.3731.3605Q62293Interferon-gamma-inducible GTPase Ifggb5 proteinTgtp11.13571.9581.0067Q8BX57--3PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)Pxk11.13550.8671.3607E0CYU9Sjoegren syndrome/scleroderma autoantigen 1 homologSssca111.1351.7051.5802Q9R0X0--3Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog)Med20 Trfp11.13351.0881.3255P18527Ig heavy chain V region 914011.1331.0710.618A2A6A1G patch domain-containing protein 8Gpatch8 Gpatc8 Kiaa055311.12951.8611.0447O35242Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation)Nsmaf Fan11.12751.1161.417P04184Thymidine kinase, cytosolic (EC 2.7.1.21)Tk1 Tk-111.12221.2881.638Q80VC9--2Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha)Camsap3 Kiaa154311.11071.3081.492S4R2K0Protein PdfPdf11.10821.6441.4732Q8BZR9Uncharacterized protein C17orf85 homolog011.1081.1321.6712Q8K4Q0--5Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein)Rptor Raptor11.1051.1531.4442Q6P9L6Kinesin-like protein KIF15 (Kinesin-like protein 2) (Kinesin-like protein 7)Kif15 Klp2 Knsl711.10121.3671.3967Q9CR76Transmembrane protein 186Tmem18611.09970.6551.0117Q924Z6--2Exportin-6 (Exp6) (Ran-binding protein 20)Xpo6 Ranbp2011.09971.2091.5217Q8BZT5Leucine-rich repeat-containing protein 19Lrrc1911.09521.3791.2207P11247Myeloperoxidase (MPO) (EC 1.11.2.2) \[Cleaved into: Myeloperoxidase light chain; Myeloperoxidase heavy chain\]Mpo11.09451.1951.415A8DUK4Beta-globin (Protein Hbb-bs) (Protein Hbb-bt)Hbbt1 Hbb-bs Hbb-bt Hbbt211.09422.140.8445P01630Ig kappa chain V-II region 7S34.1011.0941.4051.2252Q8CGN5Perilipin-1 (Lipid droplet-associated protein) (Perilipin A)Plin1 Peri Plin11.08950.8851.3687Q9CQT2RNA-binding protein 7 (RNA-binding motif protein 7)Rbm711.08771.1421.333F7BJK1Protein Pcdh1 (Fragment)Pcdh111.08750.9271.8367Q80TA6--2Myotubularin-related protein 12Mtmr12 Kiaa168211.08351.0911.5237P54754Ephrin type-B receptor 3 (EC 2.7.10.1) (Developmental kinase 5) (mDK-5) (Tyrosine-protein kinase receptor SEK-4)Ephb3 Etk2 Mdk5 Sek411.0821.3411.1597D3Z769Protein lin-37 homolog (Fragment)Lin3711.07951.1161.5232A0A075B5X9Ig heavy chain V region B1--8/186--2 (Fragment)Ighv1--7211.07951.4151.2F6TLB0DNA-directed RNA polymerase, mitochondrial (Fragment)Polrmt11.0771.1111.3495A0A087WRI5Adenylate kinase isoenzyme 6Ak611.0751.3461.1457Q8BK35MCG2065, isoform CRA_c (PreS1 binding protein) (Protein Gltscr2)Gltscr2 mCG_206511.0740.9531.557Q9CQT0tRNA(His) guanylyltransferase (EC 2.7.7.79) (tRNA-histidine guanylyltransferase)Thg1l mCG_2229611.07221.141.4462A0A075B677Protein Igkv4--53Igkv4--5311.07051.3610.986G3UWZ0Bromodomain adjacent to zinc finger domain protein 1ABaz1a11.07021.5641.3232F6R2G3Mucin-4 (Fragment)Muc411.06951.2861.3432Q6GU68Immunoglobulin superfamily containing leucine-rich repeat proteinIslr11.0681.1541.3577E9PWH6HEAT repeat-containing protein 3Heatr311.06051.1021.4625Q8BLH7HIRA-interacting protein 3Hirip311.05871.4961.4912Q62264Thyroid hormone-inducible hepatic protein (Spot 14 protein) (S14) (SPOT14)Thrsp S1411.05820.9431.4015Q99M73Keratin, type II cuticular Hb4 (65 kDa type II keratin) (Keratin-84) (K84) (Type II hair keratin Hb4) (Type-II keratin Kb24)Krt84 Krt2--16 Krthb411.05571.171.3252Q9D856Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5)Slc39a5 Zip511.05551.4841.4005F7BJB9Protein Morc3Morc311.05251.3751.2087B7ZWM8Leucine-rich repeat and calponin homology domain-containing protein 3 (Lrch3 protein)Lrch311.05051.1281.3452D3Z6K8Ras-specific guanine nucleotide-releasing factor 2Rasgrf211.04821.0471.3875Q5FWI3Transmembrane protein 2Tmem2 Kiaa141211.04621.1631.4667G3UZL2RCC1 and BTB domain-containing protein 1 (Fragment)Rcbtb111.04171.4331.2967Q61666--4Protein HIRA (TUP1-like enhancer of split protein 1)Hira Tuple111.04051.1271.3862P53569CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor)Cebpz Cbf2 Cebpa-rs111.03671.3251.7395Q9JJF3Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (Histone lysine demethylase NO66)No66 Mapjd MNCb-710911.03371.681.1642Q9DAA6Exosome complex component CSL4 (Exosome component 1)Exosc1 Csl411.0331.3261.2455A0A087WQR9NEDD8-conjugating enzyme UBE2F (Fragment)Ube2f11.02921.3521.2977Q9Z0E6Interferon-induced guanylate-binding protein 2 (GTP-binding protein 2) (GBP-2) (mGBP-2) (mGBP2) (Guanine nucleotide-binding protein 2)Gbp211.02921.4320.9467B7ZMP1--2Probable Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3)Xpnpep311.02850.9271.4122D3YWR2B-cell linker proteinBlnk11.02371.5951.1195H7BX32Nuclear envelope pore membrane protein POM 121Pom12111.01651.1871.3717Q99N8728S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt)Mrps511.01471.410.9545Q8CBC4ConsortinCnst11.00921.331.19A2AER8Polyglutamine-binding protein 1Pqbp111.00771.4770.9262A8Y5N417-beta-hydroxysteroid dehydrogenase 13Hsd17b1311.0060.6030.7325Q9D8I1Marginal zone B- and B1-cell-specific proteinMzb1 Pacap11.0061.3480.9347P26618Platelet-derived growth factor receptor alphaPdgfra11.00321.1521.4392P55088--2Aquaporin-4 (AQP-4)Aqp411.00051.3270.8442*Acc no* Accession number, *Prot name* Protein name, *SE* Semen Euphorbiae, *SEP* Semen Euphorbiae Pulveratum, *EFL*~*1*~ Euphorbiae Factor 1

GO ontology analysis {#Sec18}
--------------------

To elucidate the biological significance of these differentially modified proteins, we performed GO analysis and categorized these proteins according to their molecular function and biological process using the GO database. 295 union proteins were selected and separated into 3 categories: biological processes (Fig. [2a](#Fig2){ref-type="fig"}), cellular component association (Fig. [2b](#Fig2){ref-type="fig"}), and molecular function (Fig. [2c](#Fig2){ref-type="fig"}).Fig. 2Bioinformatics analysis of the differentially expressed proteins (ratio ≥ 1.32 or ≤ 0.68 fold). **a** Biological process (**b**) Cellular component; (**c**). Molecular function

In the biological process category, the results suggested that most of the DEPs participate in metabolic processes (32.9%), cellular processes (17.10%), biological regulation (12.6%), and response to stimulus (7.70%). In the cellular component analysis, most of the potential biomarkers are concentrated in the cell part (32.80%), organelle (20.90%), extracellular region (19.40%), membrane (11.90%) or macromolecular complex. In the molecular function analysis, the differentially expressed proteins were found to play a role in catalytic activity (34.60%), binding (32.30%), enzymatic activity (9.00%) and structural molecule activity (8.30%),suggesting that their related functions were important in the colon of mice.

On the basis of our findings, it could be concluded that the identified DEPs causing by SE, SEP and EFL~1~ were mainly associated with the cellular part. The expression sites of them located within cells and organelles. G protein and Eph/Ephrin signal pathway were controlled jointly by SE and SEP. After processing, the extracts of SEP were mainly reflected in the process of cytoskeleton, glycolysis and gluconeogenesis.

Pathway enrichment analysis and interaction network analysis {#Sec19}
------------------------------------------------------------

MetaCore™ (version 6.18) is an integrated software suite for functional analysis of experimental data. Differential pathways among SE, SEP, EFL~[1]{.ul}~ and control were conducted according to the *P* Value (*P* \< 0.05). All the differential pathways were shown in Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}.Table 3Pathway Enrichment analysis of differentially expressed proteins relative to SE compared with control groupNOMapspValue1Immune response_Oncostatin M signaling via JAK-Stat in mouse cells0.0001952Immune response_Oncostatin M signaling via JAK-Stat in human cells0.0002423Development_Thrombopoetin signaling via JAK-STAT pathway0.0002944Immune response_IL-15 signaling via JAK-STAT cascade0.0003225Development_Transcription factors in segregation of hepatocytic lineage0.0005526Immune response_IL-7 signaling in T lymphocytes0.0008877Immune response_IL-7 signaling in B lymphocytes0.0011368Cell adhesion_Ephrin signaling0.0012449Neurophysiological process_Receptor-mediated axon growth repulsion0.00124410Immune response_IL-5 signaling0.00130011Signal transduction_PTMs in IL-12 signaling pathway0.00141512G-protein signaling_Rap1B regulation pathway0.01304713Protein folding_Membrane trafficking and signal transduction of G-alpha (i) heterotrimeric G-protein0.02243814Immune response_IL-12 signaling pathway0.02710315Development_Glucocorticoid receptor signaling0.028266Table 4Pathway Enrichment analysis of differentially expressed proteins relative to SEP compared with control groupNOMapspValue1Cytoskeleton remodeling_Role of PDGFs in cell migration0.0021882Glycolysis and gluconeogenesis p.3 / Human version0.0021883Glycolysis and gluconeogenesis p.30.0021884Development_PDGF signaling via STATs and NF-kB0.0038775Normal and pathological TGF-beta-mediated regulation of cell proliferation0.0041196Cell adhesion_Ephrin signaling0.0075597Neurophysiological process_Receptor-mediated axon growth repulsion0.0075598Development_PDGF signaling via MAPK cascades0.0082249Some pathways of EMT in cancer cells0.00963110Aberrant B-Raf signaling in melanoma progression0.01113711Transport_Macropinocytosis regulation by growth factors0.01443912Glycolysis and gluconeogenesis (short map)0.01577313G-protein signaling_Rap1B regulation pathway0.03174814Cell adhesion_Chemokines and adhesion0.03425415Cytoskeleton remodeling_Cytoskeleton remodeling0.035519Table 5Pathway Enrichment analysis of differentially expressed proteins relative to EFL~1~ compared with controlNO.MapspValue1Development_Angiopoietin - Tie2 signaling0.0000272Immune response_IL-7 signaling in T lymphocytes0.0000353Immune response_IL-7 signaling in B lymphocytes0.0000514Immune response_Antiviral actions of Interferons0.0000905Immune response_Oncostatin M signaling via JAK-Stat in mouse cells0.0004256Immune response_Oncostatin M signaling via JAK-Stat in human cells0.0005267Development_Thrombopoetin signaling via JAK-STAT pathway0.0006398Immune response_IL-15 signaling via JAK-STAT cascade0.0006999Immune response_IL-23 signaling pathway0.00082710Signal transduction_PTMs in IL-23 signaling pathway0.00127411Development_PDGF signaling via STATs and NF-kB0.00135712Immune response_IL-22 signaling pathway0.00153213Development_EPO-induced Jak-STAT pathway0.00162314Development_Growth hormone signaling via STATs and PLC/IP30.00162315Immune response_IL-9 signaling pathway0.001717

Comparing with group 1(control), the pathways with higher activity were mainly related to the immune response, and also related to other physiological processes such as development and G protein pathways; the dominant signaling pathways were interleukin signaling pathway, JAK/Stat et al.; the key proteins involved in multiple pathways contain STAT1, SERPINA3, G protein Rap1B and so on. Meanwhile, group 4 (EFL~1~) showed that the physiological process with high activity was relatively simple, mainly focused on the immune response and development process. Interleukin signaling pathways, Ang/Tie 2 and NF/kB were found to be the main signaling pathways and the key proteins involved were STAT1 and STAT5; compared with control, group 3 induced cytoskeleton remodeling, glycolysis and gluconeogenesis with higher activities, signaling pathways which contain a variety of major B-Raf pathways, epithelial cells to interstitial cell transition(EMT)-related signaling pathways, cell endocytosis, etc. and PDGF receptors, Ephrin receptors,in which STAT 1 was related to the key proteins.

A network was constructed by protein-protein interaction of the 295 significantly DEPs basing on Analyze Network Algorithm using MetaCore in Fig. [3](#Fig3){ref-type="fig"} (A-D). (Tables [6](#Tab6){ref-type="table"} and [7](#Tab7){ref-type="table"}).Fig. 3Biological networks generated by different groups. **a** Protein interaction networks of DEPs from four groups after taking the intersection; **b**, **c** and **d**: protein interaction networks of DEPs from four groups after taking union (**b**: Major Histocompatibility Complex class IInetwork; **c**: Ubiquitination in Mediating the Cellular Stress Response; **d**: Interferon-γ-mediated signal transduction and response network); **e** Explanation of various symbols in the network map. The network of significantly differentially expressed proteins (ratio ≥ 1.32 or ≤ 0.68 fold) was analyzed by MetaCoreTM(version 6.18)softwareTable 6Intersection of differentially expressed protein NetworksNetworkGO processesTotal nodesSeed nodesp-ValuezScoregScoreAngiopoietin 4, NF-kB, ALDR, TIE2, ATP + PtdIns(4,5)P2 = ADP + PtdIns(3,4,5)P3response to oxygen-containing compound (70.6%; 1.570e-16), regulation of multicellular organismal process (76.5%; 2.094e-15), response to peptide (47.1%; 1.618e-14), response to stress (82.4%; 2.570e-14), positive regulation of cellular process (88.2%; 3.104e-14)5110.0024520.1622.66Table 7Union of differentially expressed protein NetworksNetworkGO processesp-ValuezScoregScoreTrypsin II, Chymotrypsin C, Trypsin 3, TATI, RAIG1antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (27.3%; 6.498e-17)1.010E-2148.7648.76Ubiquitin, Fetuin-A, UBC, RelA (p65 NF-kB subunit), TRAF2regulation of response to stress (56.5%; 6.254e-19), positive regulation of NF-kappaB transcription factor activity (28.3%; 2.556e-17)1.140E-0514.3344.33STAT1, TGTP, Mcpt4 (rodent), Sca-1, Thrombomodulininterferon-gamma-mediated signaling pathway (31.9%; 8.694e-24), response to interferon-gamma (36.2%; 1.175e-23)2.970E-1433.3733.37

Obviously, commonly pathways are mainly interleukin-mediated signaling pathways, including IL-7, IL-15, IL-23 and other inflammatory factors both controlled by EFL~1~ and SE groups. We supposed that these inflammatory factors activate the interleukin signaling pathway, NF / kB signaling pathway, and then mediate intestinal mucosal barrier injure by up-regulating inflammatory proteins expression which resulting in inflammatory response. While there is no obvious interleukin-mediated inflammatory response in SEP group. Generally speaking, inflammatory response especially interleukin might be closely related to the attenuated mechanism of Semen Euphorbiae.

According to network analysis, four reliable functional networks were found and analyzed. After intersection of four groups, the main protein interaction network was multicellular organism regulation process (only Angiopoietin 4 is the down-regulated differentially expressed protein and NF-κB is a pivotal role which interacts with other proteins in the network most closely, Fig. [3a](#Fig3){ref-type="fig"}). DEPs which were taken together mainly participated in the protein interaction networks as shown in Fig. [3b](#Fig3){ref-type="fig"}, [c](#Fig3){ref-type="fig"} and [d](#Fig3){ref-type="fig"}. MHC II presents endogenous and exogenous antigenic peptides or antigenic polysaccharides (containing 10 differential proteins, the key point is MHC class II in Fig. [3b](#Fig3){ref-type="fig"}), stress response (containing 3 up-regulation differential proteins, RelA/P65 and ubiquitin are the central part of network, Fig. [3c](#Fig3){ref-type="fig"}), γ- Interferon - mediated signal transduction and response (containing 6 up-regulation,1 down-regulation differential proteins, as shown in Fig. [3d](#Fig3){ref-type="fig"}, STAT1 interacted closely with other proteins and play an important role in the networks).

It should be pointed out that Angiopoietin 4 is the only down-regulated differential expressed protein in the interaction network. Subsequently, STAT1 was found to be the key protein shared by the EFL~1~, SEP and SE tested groups, compared with the control group. A previous study has implied that the transcription factor NF-κB (nuclear factor kappa B) plays a central role in the regulation of immune and inflammatory responses, as well as in control of cell apoptosis. These proteins participate in the regulation of a wide range of genes involved in immune, inflammatory and apoptosis function \[[@CR21]\]. Although the relationship between Angiopoietin 4 and NF-κB has not been reported, according to the network, we could make the hypothesis that SE could increase Angiopoietin 4 and then activate NF-κB to make the body produce immune or inflammatory response. In addition, interferons (IFNs) are important cytokines that play essential roles in antiviral, antibacterial, antitumor and immunomodulatory activities. IFNs primarily signals through the JAK-STAT pathway leading to the activation of signal transducer and activator of STAT and subsequent transcription of target genes \[[@CR22]\]. Based on the pathway analysis, IFN-γ could activate STATs through JAK-STAT signal pathway to initiate CIITA (typeIItranscription activator) which as MHC IItrans activator, and then the expression of MHC II were up-regulated to produce immune response and immune regulation so that the mice have diarrhea symptoms after treated with SE group. For these reasons and hypothesis, western blot analysis was then conducted to validate the two differentially expressed proteins- STAT1 and Angiopoietin 4.

Validation of differentially expressed proteins identified by proteomics {#Sec20}
------------------------------------------------------------------------

Two proteins, STAT1 and Angiopoietin 4 identified DEPs with marked differences in expression determined by iTRAQ based quantitative analysis were selected to be verified by western blot analysis (Figs. [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"}). As depicted in Figs. [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"} and Table [8](#Tab8){ref-type="table"}, Angiopoietin 4 protein was significantly down-regulated in SEH, SEPH and EFLH groups as compared with control group (*p* \< 0.05), the expression level of Ang4 in SEH was the lowest; and STAT1 was up-regulated in SEH, SEPH and EFLH groups, which levels were all higher than control group (*p* \< 0.05). Moreover, the groups of low dose of SEL, SEPL and EFLL have no significant differences compared with the control. The results which were found by western blot is consistent with the findings in iTRAQ analysis. Both of Ang-4 and STAT1 expression levels in the mice colon tissue may be dose-dependent with the increase dose of SE and SEP.Fig. 4Relative expression levels of Ang4 and STAT1were normalized to the β-actin which were quantified by densitometric analysis. These experiments were each conducted five timesFig. 5Western blotting showing the changes in Ang4 and STAT1 level in mice intestine treated with different doses of SE, SEP and EFL~1~ with respect to control-treated mice intestineNote:Internal reference:β- actin,1.Control, 2.High-dose of SE (SEH*,* 1.5 ml/20 g), 3.low-dose of SE (SEL*,* 0.5 ml/20 g), 4. High-dose of SEP (SEPH*,* 1.0 ml/20 g), 5. Low-dose of SEP (SEPL*,* 0.33 ml/20 g), 6.High-dose of EFL~1~ (EFLH*,* 20 mg/20 g), 7 Low-dose of EFL~1~ (EFLL*,* 10 mg/20 g)Table 8The relative expression of Ang4 and STAT1 in intestinal tissue of mice ($\documentclass[12pt]{minimal}
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It is well established that the angiopoietin (Ang) family of growth factors includes Ang1, Ang2, Ang3 and Ang4, all of which bind to the endothelial receptor tyrosine kinase Tie2. Ang3 (mouse) and Ang4 (human) are interspecies orthologs. Tie2 \[[@CR23]\] maintains the vascular integrity of mature vessels by enhancing endothelial barrier function and inhibiting apoptosis of endothelial cells. According to the pathway network analysis, as shown in Fig. [3a](#Fig3){ref-type="fig"}, we speculated that Semen Euphorbiae might inhibit the expression of Ang-4, which Tie-2 couldn't be activated, so that the steady state of endothelial cells was broken and the sensitivity of various inflammatory mediators increased, permeability, and thus promoted the occurrence of inflammatory response. The inhibition of Ang 4 by SEP group after processing was weakened comparing to SE group, resulting in lower diarrhea and inflammatory response.

**STAT1** has been implicated as a mediator of biological responses to a variety of growth factors and cytokines, based on ligand-dependent tyrosine phosphorylation and activation. Stat1 is a functional transcription factor even in the absence of inducer-mediated activation, participating in the constitutive expression of some genes \[[@CR24]\]. JAK2/ STAT pathway signaling is activated by a wide array of cytokines and growth factors leading to the stimulation of cell proliferation, differentiation, and apoptosis \[[@CR25]\]. And it is an important way of signal transduction of inflammatory factors.

In addition to being involved in the main JAK2 / STAT signaling pathway, STAT1 could be activated by JAK2 (non-receptor tyrosine) kinase, but also by inflammatory factors such as interleukin-6 (IL-6), tumor necrosis factor (TNF),growth factors such as interferon (IFN) \[[@CR26]\], epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and other signal activation.

As the up-regulated proteins induced by each group, STAT1 was induced by SEP group lower than the SE group so that we suspected that STAT 1 was most likely one of target proteins related to intestinal inflammation which might illustrate the attenuated mechanism of Semen Euphorbiae.

Both Ang-4 and STAT1 were surmised to be one of the target proteins inducing by Semen Euphorbiae.

Conclusions {#Sec21}
===========

This study used iTRAQ labeling followed by 2D-LC-MS/MS for the quantitative proteomic analysis of intestine samples from KM mice with different groups and control to discover candidate biomarkers for attenuated mechanism of Semen Euphorbiae processing for the first time. These findings suggest that SE induced an inflammatory response, and activated the Interleukin signaling pathway, such as the Ang/Tie 2 and JAK2/ STAT signaling pathways, which may eventually contribute to injury result from intestinal inflammatory, while SEP could ease this injury by reducing STAT1 and activating Ang-4 which could reduce the inflammatory response. Taken together, these results not only provided a novel insight into attenuated mechanism of Semen Euphorbiae, which was marked by a number of DEPs that might be associated with intestinal inflammation, but also the first experimental evidence that the Angiopoietin 4 and STAT1 proteins might be two major candidate biomarkers in the attenuated of SE after processing based on proteomic investigation. Our findings suggest that this screening method has potential valuable in studying mechanism of processing. Future systematic studies will investigate how Semen Euphorbiae regulate the expression of these key proteins and illustrate the problem from a clinical point of view.

2D-LC-MS/MS

:   Two-dimensional liquid chromatography-tandem mass spectrometry

ACN

:   Acetonitrile

Ang

:   Angiopoietin

CIITA

:   TypeIItranscription activator

DEPs

:   Differentially expressed proteins

DTT

:   Dithiothreitol

EFL~1~

:   Euphorbiae Factor 1

EGF

:   Epidermal growth factor

Eph/Ephrin

:   Erythropoientin-producing hepatocyte kinases/Eph receptor interacting proteins

GO

:   Gene ontology

IFN

:   Interferon

IgG

:   Immunoglobulin G

IL-6

:   Interleukin-6

iTRAQ

:   Isobaric tags for relative and absolute quantitation

JAK2

:   Janus Kinase 2

LC

:   Liquid chromatography

NF-κB

:   Nuclear factor kappa B

PDGF

:   Platelet-derived growth factor

PSMs

:   Peptide-spectrum matches

PVDF

:   Polyvinylidene fluoride

SDS-PAGE

:   Sodium dodecyl sulfate polyacrylamide gel electrophoresis

SE

:   Semen Euphorbiae

SEP

:   Semen Euphorbiae Pulveratum

STAT1

:   Signal transducers and activators of transcription one

TCM

:   Traditional Chinese medicine

TNF

:   Tumor necrosis factor
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